Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
about
Role of Components in the Formation of Self-microemulsifying Drug Delivery SystemsDevelopment of innovative oil-core self-organized nanovesicles prepared with chitosan and lecithin using a 2(3) full-factorial design.Novel norcantharidin-loaded liver targeting chitosan nanoparticles to enhance intestinal absorptionRole of mucoadhesive polymers in enhancing delivery of nimodipine microemulsion to brain via intranasal route.Changes in the intestinal absorption mechanism of icariin in the nanocavities of cyclodextrins.Triterpene-loaded microemulsion using Coix lacryma-jobi seed extract as oil phase for enhanced antitumor efficacy: preparation and in vivo evaluation.Absorption mechanism of DHP107, an oral paclitaxel formulation that forms a hydrated lipidic sponge phase.Nanocarriers for oral drug delivery.Advances in P-glycoprotein-based approaches for delivering anticancer drugs: pharmacokinetic perspective and clinical relevance.A critical appraisal of microemulsions for drug delivery: part I.Therapeutic potential of nanocarrier for overcoming to P-glycoprotein.Preparation of sodium cholate-based micelles through non-covalent ıbonding interaction and application as oral delivery systems for paclitaxel.Self-Microemulsifying Drug Delivery Systems: An Attractive Strategy for Enhanced Therapeutic Profile.Stable phosphatidylcholine-bile salt mixed micelles enhance oral absorption of paclitaxel: preparation and mechanism in rats.Thermoreversible Pluronic F127-based hydrogel containing liposomes for the controlled delivery of paclitaxel: in vitro drug release, cell cytotoxicity, and uptake studies.Development of a novel microemulsion for oral absorption enhancement of all-trans retinoic acid.Development and characterization of a new oral dapsone nanoemulsion system: permeability and in silico bioavailability studiesEnhancement of transdermal delivery of progesterone using medium-chain mono and diglycerides as skin penetration enhancers.Microemulsions containing medium-chain glycerides as transdermal delivery systems for hydrophilic and hydrophobic drugs.Pluronic-poly (acrylic acid)-cysteine/Pluronic L121 mixed micelles improve the oral bioavailability of paclitaxel.Enhancement on oral absorption of paclitaxel by multifunctional pluronic micelles.Lamellar liquid crystalline phases for cutaneous delivery of Paclitaxel: impact of the monoglyceride.Formulation and In-vivo Pharmacokinetic Consideration of Intranasal Microemulsion and Mucoadhesive Microemulsion of Rivastigmine for Brain Targeting.Quantitative analysis of the effect of triglyceride alkyl-chain length on the partitioning of highly lipophilic compounds to the mesenteric lymph in intestinal cells.Enhanced oral bioavailability of paclitaxel by solid dispersion granulation.Bioavailability enhancement of paclitaxel via a novel oral drug delivery system: paclitaxel-loaded glycyrrhizic acid micelles.Biopharmaceutical insights of particulate emulsified systems - a prospective overview.
P2860
Q26801043-56921FB0-67A5-44F2-B5D8-5A951B388874Q34977425-A10D09C3-0AB1-46ED-A5DF-3D5F9AA21405Q35972493-BF383A2A-8E9A-4A52-BEB3-643782118B08Q36111963-3BE4F8C6-0F84-4F4F-BAB5-74CB46BA63DBQ36161028-7266E5B2-73B4-4482-B1E2-E21A8FC305B0Q37412850-021C3406-302B-48BA-A6CE-DB0DF8FB9B91Q37571909-42702999-7F8B-43BB-AE28-66F75BACA29AQ38101960-5CDF05A7-F5F7-4C6F-8316-F1E93E1DFC64Q38167822-7BE0AF38-5DC0-457F-AFCE-1BB3B4DCDA30Q38168596-796F1928-7017-45E0-8BF4-E4D0F7E68E1DQ38237724-7554FDEA-E952-4114-A8C7-4CB0FF3BCFADQ38741030-6C9EEBFF-730E-45A9-B66D-647963B3347EQ38887547-D1B07959-B1AB-4E6B-8E42-E453C049A4C0Q38970226-0D3E0425-B1E8-4B03-B586-72F0E4518071Q39557339-3749D659-FF15-4879-B499-C267646B6C28Q41301833-D18EB292-E537-43A0-A1FA-C480A9882840Q42532054-5FAE1E3F-6460-4102-97D4-AF70938E67F7Q42797806-6617EE93-2CAA-45E8-B8DF-99BD2F854EF0Q43118129-D735A56E-5022-4A91-BD25-B7B47F02AF4AQ44014666-14D69D47-6E00-43D8-8BC8-C588A4D8E20CQ44833238-0A48898D-1663-4787-9776-73B025A48358Q45827964-04CAA3F6-5923-4781-B3CD-D8E4BD068BE0Q47733973-9BB9B119-60A4-4537-810B-EA3E745B28A2Q51158545-1697E374-CE28-47CE-81C9-D27E6D40DE87Q53229493-98706474-5B99-4C53-9AE3-53463C491680Q53583891-F17A9B48-C58F-49E5-827E-A1B1F654621CQ55004938-15ADB8EA-CB0D-4388-9271-C149695C4442
P2860
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
description
2008 nî lūn-bûn
@nan
2008 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
@ast
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
@en
type
label
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
@ast
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
@en
prefLabel
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
@ast
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
@en
P2093
P1476
Oral microemulsions of paclitaxel: in situ and pharmacokinetic studies.
@en
P2093
Adwoa O Nornoo
Haian Zheng
Luciana B Lopes
Rachel Reed
P304
P356
10.1016/J.EJPB.2008.08.015
P407
P577
2008-08-29T00:00:00Z